Hematology/Oncology

Top Story

Primary prevention improves colorectal cancer survival over early detection

November 21, 2017

Primary prevention of colorectal cancer through the removal of adenomatous polyps led to greater mortality reductions than early detection of the disease, according to an analysis of data from the PLCO cancer screening trial.

Thus, colorectal cancer screening guidelines should emphasize the importance of primary prevention, according to the researchers.

Meeting News

Causes of immunotherapy-related side effects in cancer require more research

November 21, 2017
NEW YORK — Oncologists and researchers should be more concerned with the lack of available data on the mechanisms of action behind significant…
Meeting News

Majority of women prefer annual screening mammograms, despite potential ‘harms’

November 21, 2017
More than 70% of women would rather get screened for mammograms annually, despite the current U.S. Preventive Services Task Force recommendation that women at average…

ACP: Improving health care price transparency ‘vital’

November 21, 2017
Increasing access to meaningful information, including price, cost and quality data on health care services, can aid in efforts to improve health care price transparency…
In the Journals Plus

Many cancers associated with modifiable risk factors

November 21, 2017
Cigarette smoking, excess body weight and alcohol intake represented the three most prevalent modifiable risk factors for cancer, according to an American Cancer Society…
More Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »
Video
Meeting News

VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

October 14, 2017
More »
Resource Centers

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today